News

In December 2016, University Hospital Zurich established an independent foundation to support the further development of medical technologies and innovations. Patients should be able to benefit from new and improved treatment methods quickly and directly. The Board of Foundation includes a number of well-known figures from business and academia.

A human’s microbiome – that is, the type of bacteria that colonize our gastrointestinal tract – differs from person to person in adults and has pronounced effects on the body. A new study with the participation of University Hospital Zurich reveals that the microbiome influences the prognosis in patients suffering from a heart attack.